← Back

Meinian Onehealth Healthcare Holdings Co Ltd

Meinian Onehealth Healthcare Holdings Co., Ltd. provides health checkup services and integrates health consultation, health assessment, and health management. It also offers prevention, health protection, nutrition and health management consulting, medical technology, information technology, health advisory, medical care, and insurance brokerage services. In addition, the company is involved in investment management, physical examination management, software development, and sales, and it provides research and experimental development services, sells medicines and medical devices, and engages in financial leasing, factoring, consulting, and pharmaceutical businesses. Founded in 1991, it is headquartered in Shanghai, China.

Country
Price · split & dividend adjusted
News & notes moving 002044.CS
002044.CS3

Meinian Onehealth posts net loss of 182 million yuan in 2026 interim report

Meinian Onehealth released its 2026 interim report, showing total operating revenue of 3.844 billion yuan, down 6.45 percent from the same period last year, and a net loss attributable to the parent company of 182 million yuan. Net cash flow from operating activities was negative 429 million yuan, a decrease of 6.5829 million yuan compared with the same period last year. The company's asset-liability ratio was 53.35 percent, gross margin was 33.90 percent, return on equity was negative 2.29 percent, and diluted earnings per share was negative 0.05 yuan. Total asset turnover was 0.20 times, and inventory turnover was 14.64 times. The number of shareholders was 196,300, and the top ten shareholders held 32.88 percent of total share capital.
Jiemian·19dRead more →
002044.CS

Meinian Onehealth Half-Year Report: 141 Institutions Hold 38.16%

Meinian Onehealth released its 2026 semi-annual report. As of August 30, a total of 141 institutional investors held its A-shares, with combined holdings of 1.494 billion shares, accounting for 38.16% of total share capital. Among them, the top ten institutional investors held a combined 32.88%, up 1.81 percentage points from the previous quarter. In terms of public funds, 2 increased their holdings this period, 7 decreased, 116 were newly disclosed, and 9 were no longer disclosed. One social security fund was newly disclosed, and one pension fund increased its holdings, with the increased holding proportion reaching 0.9%.
Jiemian·19dRead more →
002044.CS

Meinian Onehealth Terminates Share-Issuance Asset Purchase and Related-Party Transaction

Meinian Onehealth announced the termination of its share-issuance asset purchase and related-party transaction, and the withdrawal of its application documents. The company had originally planned to acquire equity in 11 companies including Hengyang Meinian, as well as minority stakes in five listed companies' controlled subsidiaries such as Zhengzhou Meijian, through the issuance of shares. Given the extended timeline of this transaction and significant changes in the market environment compared to the initial planning stage, the company decided to terminate the transaction after careful consideration and consultation with the counterparties, in order to protect the interests of the company and its investors.
证券时报·64dRead more →
002044.CSimpact 4

Bangjie Shares expects first-half net loss of up to 335 million yuan, restructuring underway

Bangjie Shares issued a profit warning, expecting a net loss attributable to shareholders of the listed company of between 225 million and 335 million yuan for the first half of the year. The company attributed the loss mainly to high fixed costs from the suspension of its photovoltaic subsidiary, provisions for expected losses on overdue debts, and a decline in revenue and gross margin in its knitting segment. In addition, the company lost control of its photovoltaic subsidiary Yangzhou Bangjie New Energy Technology and deconsolidated it, which had a significant impact on net profit, but it also received debt forgiveness of about 650 million yuan from creditors during the same period, positively affecting owners' equity. The company's pre-restructuring process is underway, and a draft restructuring plan has been disclosed. It plans to bring in Meinian Onehealth Healthcare Group, a subsidiary of Meinian Onehealth, as a restructuring investor, and proposes a tiered repayment scheme for ordinary claims and a divestiture of the photovoltaic business. If the plan is approved, control of the company will change. As of May 28, 2026, a total of 31 creditors had filed 32 claims, with a total claimed amount of 2.15 billion yuan. The preliminary verified claim amount is 2.124 billion yuan, of which ordinary claims account for 2.123 billion yuan and related-party claims total 661 million yuan.
澎湃新闻·66dRead more →
002044.CS2

Meinian Onehealth Expects First-Half Loss to Narrow by 11.01% to 25.01%

Meinian Onehealth disclosed its earnings forecast, expecting a net loss attributable to shareholders of the listed company of 166 million to 197 million yuan in the first half of 2026, narrowing the loss by 11.01% to 25.01% year-on-year, compared with a loss of 221 million yuan in the same period last year. The company said the industry has strong seasonal characteristics, with the traditional off-season in the first half affected by holiday distribution and the financial settlement cycles of enterprises and institutions, leading some corporate budgets and check-ups to be postponed. Overall contract signings were relatively stable, and business affected by the check-up pace will gradually be released in the second half. The company will actively promote business growth among high-quality clients in government, banking, and insurance sectors, and continue to increase the proportion of national client contracts and check-up share.
证券时报·67dRead more →